Kmg Chemicals, Inc. (KMGB) Cash Flow Statement

Click line-items for a historical chart and %

Net income	18.68M
Depreciation and amortization	14.53M
Amortization of loan costs included in interest expense	167K
Stock-based compensation expense	4.84M
Bad debt recovery
Inventory valuation adjustment
(Gain)/ loss on disposal of property
Gain on sale of animal health business
Deferred income tax expense	258K
Tax benefit from stock-based awards
Accounts receivable - trade	5.15M
Accounts receivable - other	-1.89M
Inventories	4.35M
Other current and noncurrent assets
Accounts payable	-9.23M
Accrued liabilities and other
Income taxes payable
Net cash provided by operating activities
Additions to property, plant and equipment	-14.36M
Proceeds from sale of property	0
Proceeds from sale of animal health business
Change in restricted cash
Net cash provided by/ (used in) investing activities
Net payments under revolving loan facility
Principal payments on borrowings on term loan	0
Proceeds from exercise of stock options
Tax benefit from stock-based awards
Book overdraft
Payment of dividends	-1.41M
Net cash used in financing activities
Effect of exchange rate changes of cash
Net increase/ (decrease) in cash and cash equivalents	4.91M
Cash and cash equivalents at beginning of period	7.52M
Cash and cash equivalents at end of period	12.43M
Cash paid for interest	621K
Cash paid for income taxes	9.74M

Entities mentioned with KMGB

View All Entities